MeiraGTx Holdings (MGTX) Cash from Operations (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Cash from Operations of 46631000.0 for Q4 2025, up 481.75% on a QoQ basis from 12215000.0 in Q3 2025, and up 300.34% year-over-year from 11647866.63 in Q4 2024.
MeiraGTx Holdings (MGTX) Cash from Operations (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Cash from Operations history runs 9 years deep, the most recent figure standing at 46631000.0 for Q4 2025.
- Quarterly Cash from Operations rose 300.34% year-over-year to 46631000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 46359000.0 (up 55.64% YoY) and the FY2025 annual result came in at 46359000.0, up 55.64% from the prior year.
- Cash from Operations was 46631000.0 for Q4 2025 at MeiraGTx Holdings, up from 12215000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 46631000.0 in Q4 2025 and bottomed at 43975000.0 in Q2 2025.
- A 5-year average of 16992350.0 and a median of 20993500.0 in 2021 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations tumbled 350.61% — and 2025, when it jumped 300.34%.
- MeiraGTx Holdings' Cash from Operations stood at 18828000.0 in 2021, then tumbled by 186.4% to 16267000.0 in 2022, then advanced by 10.57% to 14547000.0 in 2023, then plunged by 60.01% to 23276000.0 in 2024, then soared by 300.34% to 46631000.0 in 2025.
- Business Quant data shows MGTX's Cash from Operations at 46631000.0 in Q4 2025, 12215000.0 in Q3 2025, and 43975000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 46.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.63 Mn |
| Dec 31, 2025 | 46.63 Mn |
| Sep 30, 2025 | -12.22 Mn |
| Sep 30, 2025 | -12.22 Mn |
| Jun 30, 2025 | -43.98 Mn |
| Jun 30, 2025 | -43.98 Mn |
| Mar 31, 2025 | -36.80 Mn |
| Mar 31, 2025 | -36.80 Mn |
| Dec 31, 2024 | -23.28 Mn |
| Dec 31, 2024 | -23.28 Mn |
| Sep 30, 2024 | -25.02 Mn |
| Sep 30, 2024 | -25.02 Mn |
| Jun 30, 2024 | -19.46 Mn |
| Jun 30, 2024 | -19.46 Mn |
| Mar 31, 2024 | -36.74 Mn |
| Mar 31, 2024 | -36.74 Mn |
| Dec 31, 2023 | -14.55 Mn |
| Dec 31, 2023 | -14.55 Mn |
| Sep 30, 2023 | -24.41 Mn |
| Sep 30, 2023 | -24.41 Mn |